DA

DRUG2 trials

Sponsors

Karolinska University Hospital, Astellas Pharma Inc

Conditions

Acute Myeloid LeukemiaChronic Kidney Disease

Phase 2

Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML

TerminatedNCT01794169

Karolinska University HospitalAcute Myeloid Leukemia

Start: 2013-03-31End: 2018-03-31Target: 130Updated: 2015-09-22

Phase 3

A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia

CompletedNCT02988973

Astellas Pharma IncChronic Kidney Disease

Start: 2017-01-12End: 2020-03-26Updated: 2024-10-31

Related Papers

Clinical parameters among patients in Japan with anemia and non-dialysis-dependent chronic kidney disease with and without diabetes mellitus who received roxadustat

Clinical and Experimental Nephrology2022-04-2411 citations

Two Phase 3 Studies on Ophthalmologic Effects of Roxadustat Versus Darbepoetin.

2022-01-197 citations

Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients

American Journal of Nephrology2021-01-0123 citations